The 1st International Electronic Conference on Medicine
Part of the International Electronic Conference on Medicine series
20–30 Jun 2021
Cardiology, Surgery, Dentistry, Hepatology, Endocrinology, Neurology, Gynecology, Gastroenterology, Complementary and Integrative Medicine
- Go to the Sessions
- Event Details
Welcome from the Chair
It is our pleasure to invite you to contribute to the First International Electronic Conference organized by the peer-reviewed journal Medicina, Kaunas, published by MDPI.
The event will occur online over from 20-30 June 2021, and it is now possible to log in as an author.
The aim of the conference is to bring together researchers from all over the world to present their latest research, receive direct feedback, and engage in discussions with the wider scientific community.
The scope of the first Medicina e-conference is to cover a wide breadth of varied research and to provide a forum for presenting and discussing new results.
Topics of interest include but are not limited to:
Moreover, during the conference, a number of internationally renowned speakers will share their current state-of-the-art research through a series of pre-recorded talks and free live-streaming webinars, which will also include Q&A sessions to allow audience participation.
We hope that you will join this conference to exchange ideas, merge different areas of expertise, and engage in successful collaborations.
IECMD2021 Live Sessions Recordings
Live Session 1
22 June 2021
Live Session 2
24 June 2021
Call for Papers
The 1st International Electronic Conference on Medicina will be held from 20–30 June 2021. IECMD aims to promote and advance the exciting and rapidly changing field of Medicine, from research to clinical practice. All proceedings will be held online athttps://sciforum.net/conference/IECMD2020.
Topics of interest include, but are not limited to:
- Cardiology
- Surgery
- Dentistry
- Hepatology
- Endocrinology
- Neurology
- Gynecology
- Gastroenterology
- Complementary and Integrative Medicine
IECMD is a virtual conference sponsored by Medicina. Participation is free of charge for authors and attendees. Accepted papers will be gathered in the Proceedings of the conference. Selected extended versions of the papers will be published in Medicine conference regular submission (ISSN 1010-660X; Impact Factor: 1.205 (2019). IECMD offers you the opportunity to participate in this international, scholarly conference without having the concern or expenditure of travel—all you need is your computer and access to the Internet. We would like to invite you to “attend” this conference by presenting your latest work.
Abstracts (in English) should be submitted before 30th April 2021 online at https://www.sciforum.net/login. For accepted abstracts, the proceedings paper can be submitted by 20th May 2021. The conference will be held from 20-30 June 2021.
Conference Secretariat
Ms. Helen Meng
Ms. Jovana Mitic
Conference Email: iecmd2021@mdpi.com
Conference Chair
Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania
Conference Committee
Faculty of Medicine, University of Oulu, Oulu, Finland,
Centre for Sport, Exercise and Osteoarthritis Research Versus Arthritis, Queen’s Medical Centre, Nottingham, UK
Director, Cardiovascular Translational Research Center, Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, USA
NYU Long Island School of Medicine and NYU Winthrop Hospital, USA
Department of General Surgery and Surgical-Medical Specialties, School of Dentistry, University of Catania, Italy
UND Life Sciences, USA
“Mater Domini” Teaching Hospital, “Magna Graecia” University, Catanzaro, Italy
University of Thessaly and Assisted Reproduction Technology Unit (ART) of the Obstetrics and Gynaecology Clinic of the University Hospital of Larisa, Greece
Department of Nephrology, Hypertension and Kidney Transplantation, Medical University of Lodz, Lodz, Poland
Attikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens Greece
Lithuanian University of Health Sciences, Kaunas, Lithuania
Department of Surgery, University of South Florida, FL, USA
Radiologie & Oncologie Interventionnelles, Sorbonne Université, Hôpital Tenon, Paris, France
The Maurice and Gabriela Goldschleger School of Dental Medicine, Tel Aviv University, Israel
Institute of Histology and Embryology, Faculty of Medicine, Comenius University in Bratislava, Slovak Republic
Cooperative Studies Program Epidemiology Center, Health Services Research and Development (DVAHCS/Duke Affiliated Center), Durham, NC, USA
Lithuanian University of Health Sciences, Kaunas, Lithuania
Emergency Medicine Department of Medical-Surgery Sciences and Translational Medicine, University of Rome Sapienza, Rome, Italy
IRCCS, Ospedale Policlinico San Martino, University of Genova, Genova, Italy
Keynote Speakers
Emergency Medicine Department of Medical-Surgery Sciences and Translational Medicine, University of Rome Sapienza, Rome, Italy
Graduate in Medicine “cum laude” (University of Naples), 1978. Postgraduate “cum Laude” in Internal Medicine (University of Naples), 1983. Postgraduate “cum Laude” in Cardiology (University of Naples), 1987. Professor of Internal Medicine, Cardiologist and Internist at Faculty of Medicine and Psychology, Department of Medical and Surgery Sciences and Translational Medicine, at University “La Sapienza” Rome, Italy and Director Emergency Medicine and postgraduate School of Emergency Medicine, Faculty of Medicine and Psychology, University “La Sapienza” Rome since 2001; Director of Emergency Medicine at Sant’ Andrea Hospital from 2001. Director Territory Emergencies and Telemedicine Programme, ASL Latina-University of Rome Sapienza. Previously University formation and positions in the Clinical and Experimental Medicine Department at Medical School of ’University “Federico II” in Naples from 1978 and was Professor Assistant at the Cardiovascular Research Institute at New York Medical College from 1994 to 1996. Clinical experience in Cardiology, Internal, and Emergency Medicine at Policlinico Federico II Faculty of Medicine at University of Naples from 1978 to 2000 and as Director of Emergency Medicine Department Sant’ Andrea Hospital La Sapienza University of Rome since 2001. Past President of GREAT Global Research on Acute Conditions Team and actual President of GREAT Global Research on Acute Conditions Team Italy. Official Coordinator at the “Sapienza “University Rome for International Cooperation in teaching and research programs with many prestigious Universities worldwide including UCSD San Diego (USA) where he is the visiting professor cooperating in research in the field of biomarkers in Emergency medicine and Aging and Longevity. He is also an Expert Professor in Medicine and Cardiovascular Prevention at Lund University Malmoe (Sweden) and the Ministry of Health World Class Professor Program at Brawijaya University Malang (Indonesia) Author of more than 300 Papers/books in the field of Cardiology, Intensive Care, and Emergency Medicine.
heart failure; acute cardiovascular disease; biomarkers in critical care
University of Thessaly and Assisted Reproduction Technology Unit (ART) of the Obstetrics and Gynaecology Clinic of the University Hospital of Larisa, Greece
I’m Assistant Professor of Embryology, School of Health Sciences, Faculty of Medicine, University of Thessaly, Greece. I m appointed as a Head of the Embryology Lab of the ART Unit of the Obstetrics and Gynecology University Clinic of the University Hospital of Larisa in Greece. My research interests are mainly the quality of spermatozoa and oocytes and the impact on fertilization and IVF outcome. Moreover, the effect of cryopreservation on both gametes and embryos and the environmental factors that may affect the quality of the gametes are also within my research interests. Molecular embryology and the molecular pathways that might be affected by the IVF procedures are my ambient future research interests. I have published more than 60 papers with a total impact factor of more than 160 and more than 1400 citations. I’m serving as an Editorial Board/Associate Editor/ Section Editor in three International Journals and I have reviewed more than 400 scientific works in about 90 Journals.
quality of embryos; spermatozoa; IVF/ICSI; molecular embryology; IVF success/failure; assisted oocyte activation; time-lapse; pre-implantation genetic diagnosis (PGD); fertilization; ovarian stimulation; cryopreservation/vitrification; sperm/oocyte bankin
Invited Speakers
Division of Cardiology, Interventional Cardiology, Brody School of Medicine at East Carolina University, Greenville, NC, USA
Dr. Ashesh N. Buch is an Interventional Cardiologist, licensed in the states of North Carolina and Virginia, U.S.A. with inactive U.K. GMC licensure. He attended the University of Birmingham Medical School in Birmingham, U.K., qualifying in 1992 following which he underwent residency training at University Hospitals North Midlands, Stoke-on-Trent, U.K. Cardiology training, dedicated time in research leading to his MD degree and interventional cardiology training were in the West Midlands Deanery. His interventional training was at the University Hospitals North Midlands, Stoke-on-Trent and University Hospitals of Coventry and Warwickshire, Coventry, U.K. followed by further interventional fellowship experience at the Washington Hospital Centre in Washington, D.C., USA. Dr Buch was a Consultant Cardiologist from 2007-2012 at University Hospital Wales, U.K. and academic faculty at East Carolina University (ECU), Greenville, NC, USA, Associate Professor with Tenure and working in Vidant Medical Center from 2012- late 2020. His areas of interest are complex, high-risk coronary intervention, coronary physiology, cardiogenic shock, and real-time perfusion imaging. He is board-certified (ABIM) in internal medicine, cardiology, and interventional cardiology with E.U. CCT in Cardiology. He recently joined Chesapeake Regional Hospital, Virginia, USA, to help build their program. He has trained a large number of physicians on both sides of the Atlantic with active research interests in clinical physiology and cardiogenic shock.
high-risk coronary intervention; coronary physiology; cardiogenic shock,; real-time perfusion imaging
IRCCS, Ospedale Policlinico San Martino, University of Genova, Genova, Italy
Professor Simone Ferrero obtained his Degree in Medicine and completed his Gynecology and Obstetrics training at the University of Genoa, Italy. He received his Ph.D. at the Queen Mary University of London, performing studies on the proteomic analysis of peritoneal fluid of women with endometriosis. Currently, he is an Associate Professor of Gynecology and Obstetrics at the University of Genoa. Professor Ferrero published over 200 peer-review articles, had several presentations in national and international meetings and edited several books. The main topics of his research are endometriosis, uterine fibroids, reproductive surgery and gynaecological oncology.
angiogenesis; gynecological surgery; intrauterine growth restriction; preterm delivery
Division of Infectious and Tropical Diseases, ‘Magna Graecia’ University of Catanzaro, Catanzaro, Italy
Dr. Maria Mazzitelli is an infectious and tropical disease specialist, graduated at Magna Graecia University of Catanzaro. She is also going to finish her PhD course in life science at Magna Graecia University of Catanzaro. Dr Maria has a special interest in HIV and comorbidities, a field of experience she dept as a research physician at Chelsea and Westminster Hospital (London, UK). During COVID-19 she participated in several local and national protocols, being author or co-author of different papers.
infection; infectious disease epidemiology; infectious and tropical disease
Instructions for Authors
Submissions should be made by authors online by registering with www.sciforum.net, and using the "New Submission" function once logged into the system.
- Scholars interested in participating in the conference can submit their abstract (about 200–300 words) online on this website until 30th April 2021.
- The Conference Committee will notify the acceptance of the abstract by 10 May 2021.
- In case of acceptance, authors will be asked to submit their manuscript, along with a presentation and optionally a video presentation of his/her paper (only PDF), until the submission deadline of 31st May 2021.
- The manuscripts and presentations will be available on https://sciforum.net/conference/IECMD2021 for discussion and rating during the time of the conference from 20-31 June 2021.
- All accepted extended abstracts will be published as one dedicated volume in MDPI Medical Sciences Forum (ISSN 2673-9992, https://www.mdpi.com/journal/msf).
Manuscripts for the proceedings issue must have the following organization:
First page:
- Title
- Full author names
- Affiliations (including full postal address) and authors' e-mail addresses
- Abstract
- Keywords
- Introduction
- Methods
- Results and Discussion
- Conclusions
- (Acknowledgements)
- References
Manuscripts should be prepared in MS Word or any other word processor and should be converted to PDF format before submission. The publication format will be PDF. The manuscript should be at least three pages (incl. figures, tables and references). There is no page limit on the length, although authors are asked to keep their papers as concise as possible.
Authors are encouraged to prepare a presentation in PowerPoint or similar software, to be displayed online along with the manuscript. Slides, if available, will be displayed directly on the website using the https://sciforum.net/conference/IECMD2020proprietary slide viewer. Slides can be prepared in exactly the same way as for any traditional conference where research results are presented. Slides should be converted to PDF format before submission so that our process can easily and automatically convert them for online display.
Besides their active participation within the forum, authors are also encouraged to submit video presentations. If you are interested in submitting a video presentation, please contact the conference organizer at iecmd2020@mdpi.com to find out more about the procedure. This is an unique way of presenting your paper and discussing it with peers from all over the world. Make a difference and join us for this project!
Authors that wish to present a poster only, i.e., without proceedings paper, can do so in section I. Posters of this conference. Posters will be available on this conference website during and after the event. Like papers presented on the conference, participants will be able to ask questions and make comments about the posters. Posters that are submitted without paper will not be included in the proceedings of the conference.
Submission: Manuscripts should be submitted online at https://sciforum.net/conference/IECMD2021 by registering and logging in.
Accepted File Formats
- MS Word: Manuscripts prepared in MS Word must be converted into a single file before submission. When preparing manuscripts in MS Word, the Electronic Conference on Medicine Microsoft Word template file (see download below) must be used. Please do not insert any graphics (schemes, figures, etc.) into a movable frame which can superimpose the text and make the layout very difficult.
- LaTeX: Manuscripts prepared in LaTeX must be collated into one ZIP folder (include all source files and images, so that the Conference Secretariat can recompile the submitted PDF). When preparing manuscripts in LaTeX, please use the 6th Electronic Conference on Sensors and Applications LaTeX template files.
Paper Format: A4 paper format, the printing area is 17.5 cm × 26.2 cm. The margins should be 1.75 cm on each side of the paper (top, bottom, left, and right sides).
- Formatting/Style: Papers should be prepared following the style of Medicine. The full titles and the cited papers must be given. Reference numbers should be placed in square brackets [ ], and placed before the punctuation; for example, [1,2], [3] or [1–3], and all the references should be listed separately and as the last section at the end of the manuscript.
- Author List and Affiliation Format: Authors' full first and last names must be given. Abbreviated middle names can be added. For papers written by various contributors a corresponding author must be designated. The PubMed/MEDLINE format is used for affiliations: complete street address information including city, zip code, state/province, country, and email address should be added. All authors who contributed significantly to the manuscript (including writing a section) should be listed on the first page of the manuscript, below the title of the article. Other parties, who provided only minor contributions, should be listed under Acknowledgments only. A minor contribution might be a discussion with the author, reading through the draft of the manuscript, or performing English corrections.
- Figures, Schemes and Tables: Authors are encouraged to prepare figures and schemes in color. Full color graphics will be published free of charge. Figures and schemes must be numbered (Figure 1, Scheme I, Figure 2, Scheme II, etc.) and an explanatory title must be added. Tables should be inserted into the main text, and numbers and titles for all tables supplied. All table columns should have an explanatory heading. Please supply legends for all figures, schemes and tables. The legends should be prepared as a separate paragraph of the main text and placed in the main text before a table, a figure or a scheme.
For further enquiries please contact us at iecmd2020@mdpi.com.
It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state here "The authors declare no conflict of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Financial support for the study must be fully disclosed under "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their scholarly works. Hence, by submitting a Communication paper to this conference, you retain the copyright of your paper, but you grant MDPI the non-exclusive right to publish this paper online on the Sciforum.net platform. This means you can easily submit your paper to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).
List of accepted submissions (10)
Id | Title | Authors | Poster PDF | ||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
sciforum-044869 |
Medico-Social Implications of Pregnancy in Teenager Mothers
, , , Corneliu Zaharia ,
Adrian Boeru ,
Elena Pop-Tudose ,
Andrei Necsulescu ,
Submitted: 15 May 2021 Abstract: Show Abstract |
,
,
,
Corneliu Zaharia ,
Adrian Boeru ,
Elena Pop-Tudose ,
Andrei Necsulescu ,
|
N/A |
Show Abstract |
|||||||||||||||||||||||||||||||||||||
Background and objective: For most teenagers, pregnancy brings insecurity, problems, fear and many questions. The main objective of this research is to determine the outlined profile of the pregnant teenager and the medical implications associated with pregnancy in mothers under 18 years of age. Materials and methods A cross-sectional questionnaire-based study was carried out in 2019 and 2020 in Ploiesti, Romania. A total of 200 childbearing women who gave birth at the Hospital of Obstetrics and Gynaecology with ages between 13- 42 years participated voluntarily in this study with given informed consent. Out of them 100 were under 18 years of age (group A). The group B (control group) consisted of 100 childbearing women with ages over 18 years. The questionnaire was composed of 29 closed questions, administered by the same investigator in a face-to-face interview, contained general data of childbearing women, (age, marital status, place of residence, number of children, occupation, level of education, ability to understand medical terms – health literacy- by applying the Sahl test) and aspects related to the family environment, (parental education, parental occupation , characteristics of the dwelling, number of siblings). Beside the questionnaire, data about the obstetrical profile of the childbearing woman, data about the birth and the new-born baby were collected. The resulting data were centralized in a database, gathering all the data from the questionnaire and as well as from the observation sheets. Results Teenager childbearing women (mothers under 18 years of age) from group A had an average age of 16.56 ± 1.65. The highest frequency of births was at 17 years of age. The percentage of births in very young girls (13-15 years old) accounts for 28% (N=28). The analysis of the two groups showed that only 40 mothers under 18 years of age came from families whose parents have a registered marriage (P= 0.011 as compared to the control group). We found that in 65 teenagers the beginning of sexual life took place at an earlier age (under 14 years). Regarding pregnancy monitoring, expressed by the number of medical checkouts and examinations, there are significant differences between the studied groups (P<0.001). The lack of health education and knowledge of medical terms is evident in the group of teenage childbearing women. The application of the Sahl test to both groups showed a low level of health literacy in the group of teenager childbearing women, 84 cases vs. 35 cases in the control group. When studying the number of medical investigations performed during pregnancy, we found significant differences (P<0.001): only 116 childbearing women from both groups performed medical investigations during pregnancy and only 42 were teenagers from these 116. Of 95 childbearing women from both groups who had hospitalizations during pregnancy, 56 were from the group of teenager mothers compared to 39 from the control group (p = 0.016). Teenager childbearing women gave birth to children with low weight for their gestational age (P<0.001 compared with the control group): in group A there were 14% and in group B only 4%. Regarding the gestational age, in the case of teenage mothers we had an average of 37.88 ± 2.13 weeks of gestation with a median of 38 weeks, compared to the gestational age in the control group of 38.41 ± 1.57 weeks, median of 39 weeks. Conclusions In Romania there are teenagers that became mothers at early ages. A pregnancy at an age between 13-15 years may come with medical implications, both physically and mental, thus medical supervision is important. Sexual and contraceptives' education in school and in the family may help the teenagers to control the possibility of becoming pregnant at such an early age. Therefore such type of educational programs must exist in rural and urban schools and communities. The midwife may play an essential role in the rural communities. A better management and multidisciplinary approach is needed. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-044880 |
Mortality in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study and Systematic Review |
,
,
Jolanta Dadonienė
|
Show Abstract |
||||||||||||||||||||||||||||||||||||||
Background and Objectives: Mortality rates among patients with rheumatoid arthritis (RA) have been reported to be higher than in the general population. The long-term prognosis of RA has improved in recent years due to early diagnosis as well as effective pharmacological treatment and may be able to diminish the excess mortality risk. This study was designed to investigate mortality (a) in patients with RA in a retrospectively defined national RA cohort in comparison with the general Lithuanian population and (b) to conduct a systematic review of the literature from different countries and meta-analysis. Material and methods: In this national retrospective cohort study patients with the first-time diagnosis of RA during the period between 1 January 2013 and 31 December 2017 were identified from the Lithuanian Compulsory Health Insurance Information System database SVEIDRA. All cases were cross-checked with Health Information center at the Institute of Hygiene, for the vital status of these patients and date of death if the fact of death was documented. The standardized mortality ratios (SMRs) with 95% confidence intervals (CIs) obtained for all-cause mortality in patients with RA adjusted for age, sex, and calendar year, were calculated. The search for published studies by a combination of keywords “rheumatoid arthritis AND standardized mortality ratio” was performed in MEDLINE (via PubMed, OVID and EBSCO), Science Direct, Tylor & Francis, Springer databases. Studies were selected according to described inclusion and exclusion criteria listed in the paper and a meta-analysis was conducted. A random-effect meta-analysis model was used to compute the pooled standardized mortality ratios (meta-SMRs). Results: Overall, 4 623 patients with newly diagnosed RA during the 2013–2017 period were identified and enrolled in the Lithuanian population-based cohort. The mean age of patients at the time of RA diagnosis was 58.7 (standard deviation (SD) 15.1) years, and 77.1% of the patients were women. The estimated SMR for all-cause mortality was 1.15 (95% CI 1.02, 1.29). The SMR for men (SMR 1.14, 95% CI 0.94, 1.39) was higher than for women (SMR 1.03, 95% CI 0.89, 1.19). A systematic literature search revealed 12 studies meeting the inclusion criteria, starting from 2010 to 2020, representing 50 072 patients. The meta-SMR in patients with RA for all-cause mortality was 1.41 (95% CI 1.29, 1.55). All-cause mortality risk was higher for men (meta-SMR 1.53, 95% CI 1.31, 1.78) than for women (meta-SMR 1.46, 95% CI 1.2, 1.77). Conclusions: In a retrospectively defined population-based national RA cohort a 15% excess risk of death was observed among patients with RA compared to the general Lithuanian population. Patients with RA have a higher mortality risk than the general population. Published data indicate that the risk of mortality is increased by 41% in patients with RA compared to the general population. Excessive all-cause mortality risk is higher in males than in women. National data showed lower standardized mortality if compared to literature data. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-043493 |
The Effect of Post-ICU Physiotherapy on Respiratory and Physical Functioning Status in Patients with COVID-19: A Pilot Study
Eirini Grammatopoulou ,
Dimitra Sdravou ,
Foteini Gkiliri ,
Aikaterini Bourtzi ,
Artemisia Polymerou ,
,
Eleni Geka ,
,
,
Submitted: 12 May 2021 Abstract: Show Abstract |
Eirini Grammatopoulou ,
Dimitra Sdravou ,
Foteini Gkiliri ,
Aikaterini Bourtzi ,
Artemisia Polymerou ,
,
Eleni Geka ,
,
,
|
N/A |
Show Abstract |
|||||||||||||||||||||||||||||||||||||
Background and Objectives: According to the recent physiotherapy recommendations (WHO, WCPT, 2020) for patients with COVID-19, after discharge from ICU, they are expected to experience respiratory, physical, cognitive, and psychological problems due to the duration and nature of the immobilization and sedation, ventilation duration, and underlying morbidity. Moreover, only patients with a limitation in physical capacity and/or physical activity have an indication for physiotherapy. However, little is known about the effect of physiotherapy treatment on the functional capacity of patients with COVID-19. Purpose: The aim of the present study was to provide information for the effectiveness of physiotherapy intervention on the respiratory and physical functional status of patients with COVID-19, since there will be a great demand for physiotherapy treatment for these people soon. Materials and Methods: The Ethics Committee of the AHEPA University Hospital, School of Medicine, Health Sciences Faculty, Aristotle University of Thessaloniki, Greece granted approval for this study. This pilot clinical study was conducted from March to June 2020. The sample consisted of 11 patients with COVID-19, discharged form ICU and hospitalized in the COVID-19 clinic of AHEPA University Hospital. All participants had indication for physiotherapy, according to the recommendations, and medical referral as well. The duration of their hospitalization ranged from two to six weeks. Among participants, there were seven males and four females, aged from 44 to 75 yrs, five smokers and six nonsmokers, four obese and seven nonobese. According to the recommendations, physiotherapy intervention was tailored to the patients’ needs and goals. Breathing exercises, early mobilization and self-management for daily living were performed once a day, for five days a week, as tolerated. Measurement tools: Pulse Oximeter (SpO2), Respiratory Rate (RR), Borg scale (intensity of dyspnea), Medical Research Council scale for disability (MRCd), clinical evaluation for dysfunctional breathing (DB), Medical Research Council scale for muscle strength (MRCms), Berg balance scale, Sit to Stand test (leg strength and endurance), Time Up and Go test (TUG) (general mobility), 1 minute walk test (1MWT) (aerobic capacity) and Barthel Index (BI) (performance in daily activities). For the purposes of the study, two measurements were conducted: at admission and at discharge from the COVID-19 clinic. Results: Dependent samples tests showed a significant effect (p <0.001) for the recommended physiotherapy treatment on respiratory variables: 6.9(1.4) % for SpO2, 3.4(0.9) breaths for Respiratory Rate, 5.0(1.3) for Borg scale score. Significant improvements (p <0.001) were additionally noted for physical functioning: 25.3(13.0) for Berg balance scale, 18.5(11.2) for MRCms score, 3(1.3) s for Sit to Stand and 40.4(40.6) s for TUG efforts, 44.1(25.5) s for 1MWT and 65.9(20.2) for BI. All patients displayed DB at admission to the COVID-19 clinic, while nine of them adopted a diaphragmatic breathing pattern at discharge. At admission to the COVID-19 clinic, all patients were at level 5 disability (MRCd), whereas at discharge 10 out of 11 patients improved (three at level 4, four at level 3 and three at level 2). Conclusion: The present pilot study provided a first evidence for the effectiveness of the WHO and WCPT physiotherapy recommendations on the respiratory and physical functioning status of patients with COVID-19. Further studies are needed to support these early findings. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-045153 |
Diagnosis of Psychosocial Risk Determinants and the Prioritization of Organizational Intervention Objects Among Medical Occupational Groups in a Public Healthcare Institution |
, , |
Show Abstract |
||||||||||||||||||||||||||||||||||||||
Background and Objectives: As the work environment is one of the most significant sources of stress, employers in the European Union are obliged to identify psychosocial risk determinants and take preventive measures to improve workers' health and well-being while at work. The aim of this study was to determine which medical occupational group is the most exposed to stress and where any differences lie between medical occupational groups regarding the perception of psychosocial risk determinants and organizational intervention objects in the Lithuanian public healthcare institution. Material and Methods: Using a cross-sectional study design, paper questionnaires were delivered to all health workers (n = 690) of the Lithuanian public healthcare institution; the response rate 68% (n = 467). The questionnaire consisting of three parts was completed for the survey. It covers 14 psychosocial risk determinants, 10 organizational intervention objects, sociodemographic data of health workers. Results: The results showed that perceived stress had mean rank scores differing statistically significant (p-value <0.05) across occupational groups. The highest stress rating was given by a doctors’ group. Regarding psychosocial risk determinants, there were statistically significant differences (p-value <0.05) in work overload scores among doctors, heads of units, other health workers; in overtime scores and in tight deadlines scores between doctors and other health workers; in unclear role scores among all medical occupational groups; in being under-skilled for a job scores between nurses and doctors; in responsibility for decision making scores among heads of units, doctors, other health workers. Concerning organizational intervention objects, there were statistically significant differences (p-value <0.05) in work-life balance scores, ensuring skills/abilities matching to the job demands scores, social support scores, organizational support scores, participation in decision-making scores, justice of reward scores, manager feedback scores, variety of tasks scores among heads of units, doctors, nurses, other health workers. Conclusions: The results of the study confirmed that different occupational groups emphasized different psychosocial risk determinants and organizational intervention objects. The findings suggest that focusing on the average worker do not have practical value, and that it is important to understand the differential effects of different job characteristics on work outcomes considering occupational status while developing coping strategies in the institution. The risk group with the most exposed to stress were doctors in the healthcare institution. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-045456 | Five Year Follow-Up of Cryptogenic Stroke Patients Following Pfo Closure |
,
,
Krista Lazdovska ,
,
Ainārs Rudzītis ,
|
N/A |
Show Abstract |
|||||||||||||||||||||||||||||||||||||
Background and Objectives: According to guidelines PFO closure is recommended for secondary stroke prevention in patients with cryptogenic stroke [1]. Paradoxial embolism from PFO mediated right to left shunt has been described as the mechanism of stroke in these cases [2]. The aim of the study is to follow-up patients after PFO closure and determine the long-term effectiveness on reccurent stroke risk reduction. Materials and Methods: A total of 103 patients were enrolled in a retrospective study and followed-up by phone up to five years after PFO closure. Standardized survey was conducted about their well-being, recurrent cerebrovascular events, and the use of prescribed medication. Patients were also followed up for residual shunts 24 h, 30 days, 1 and 2 years after PFO. The pathogenic ischemic stroke subtypes are determined using CCS (Causative Classification System for Ischemic Stroke). Results: 43.7% (n = 45) of patients were male. The mean age – 44.4 ± 13 (18–75). 53.4% (n = 55) of patients with possible cardio-aortic embolism the most probable cause for cryptogenic stroke was PFO. Residual shunts were mostly observed in patients with Amplatzer occluder – 87.5% (n = 14). There was correlation between residual shunt and increased risk of transient ischemic attack recurrence (p = 0.067). Five-years after PFO closure recurrent cerebrovascular events were reported in only 5.1% (n = 5) of patients, this difference is statistically relevant (p < 0.001). Out of 51 patient presented with complaints before PFO closure, 25.5% (n = 13) did not present with any complaints after PFO closure. Conclusions: PFO can be considered a possible risk factor for cryptogenic stroke. PFO closure is effective in reducing recurrent cerebrovascular events. Residual shunt after PFO closure increases the risk of transient ischemic attack recurrence. Amplatzer occluder device is associated with a higher risk for residual shunts after PFO closure. PFO closure can be associated with improvement of complaints. |
Event Awards
To acknowledge the support of the conference esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to launch the Best Paper Award.
The Awards
Number of Awards Available: 1
The Best Paper Award is given for the paper judged to make the most significant contribution to the conference.Terms and Conditions:
As a sponsor, Medicina would like to award the best paper as elected by all the conference committee. The award will consist of 500 Swiss Francs. We look forward to posting your contributions.
Criteria for Evaluation of Best Paper Award:
Criteria
- Full paper must be submitted to IECMD 2021;
- Originality/Novelty of the paper;
- Significance of Content;
- Scientific Soundness;
- Interest to the readers;
- English language and style.
Evaluation
- Each Evaluation Committee member will give an assessment for each applicant in terms of the criteria outlined above;
- Total score for each presentation will be ranked, from highest to lowest;
- If two or more authors get the same score, further evaluation will be carried out;
- All decisions made by the Evaluation Committee are final.
2. Cardiology and Cardiovascular Medicine
Session Chair
Dr. Allison B. Reiss, NYU Long Island School of Medicine and NYU Winthrop Hospital, USA
3. Neurology
Session Chair
Dr. Allison B. Reiss, NYU Long Island School of Medicine and NYU Winthrop Hospital, USA
Show all published submissions (2) Hide published submissions (2)
Submissions
List of Papers (2) Toggle list
5. Oncology
Show all accepted abstracts (1) Hide accepted abstracts (1)
List of Accepted Abstracts (1) Toggle list
7. Endocrinology, Diabetes and Metabolism
Show all accepted abstracts (1) Hide accepted abstracts (1)
List of Accepted Abstracts (1) Toggle list